Medical commentary has circulated regarding the potential duration of Hurts’ absence and the seriousness of the clot. While the label “superficial” suggests a less severe clot, analysts noted that the wording in the team’s announcement could carry implications for the healing process and return timeline.
Dr. David J. Chao, a former team physician with the San Diego Chargers who shares medical insights publicly, pointed out a particular term in the Eagles’ statement: movement. On social media, he cautioned that “movement” is not a medical term and suggested that if the clot were to propagate from a superficial form to deep vein thrombosis (DVT), the treatment could involve anticoagulation therapy and a longer absence from play.
The possibility of a progression to DVT would raise significant concerns and could necessitate extended rest and careful medical management for Hurts. As a result, the Eagles are expected to proceed cautiously, prioritizing Hurts’ health over a rushed return to the field.
For now, the situation calls for patience as the team evaluates Hurts and outlines a clear return-to-play plan. Updates on his condition and an official timeline will come from the team as medical assessments continue.
Note: This article reflects ongoing developments and expert opinions without speculating beyond established medical considerations.
